SECURITIES AND EXCHANGE COMMISSION

FORM 10-Q

QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD
ENDED JUNE 30, 2004

COMMISSION FILE NUMBER: 001-15941

UTEK CORPORATION

DELAWARE
(State or Jurisdiction of
Incorporation or Organization)

59-3603677
(IRS Employer
Identification No.)

202 S. Wheeler Street
Plant City, FL 33563
(Address of Principal Executive Offices)

REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE: (813) 754-4330

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 12 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter periods as the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES x   NO o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
YES o   NO x

On August 2, 2004, there were 5,501,899 shares outstanding of the
Registrant’s common stock, $0.01 par value.

Page 1 of 35

UTEK CORPORATION

FORM 10-Q INDEX

Page 2 of 35

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

UTEK Corporation

See accompanying notes

Page 3 of 35

UTEK Corporation

See accompanying notes

Page 4 of 35

UTEK Corporation

See accompanying notes

Page 5 of 35

UTEK Corporation

See accompanying notes

Page 6 of 35

UTEK Corporation

(1)		Calculated based on diluted weighted average number of shares outstanding during the period
(2)		Excluding income taxes

See accompanying notes

Page 7 of 35

UTEK CORPORATION

Page 8 of 35

Notes to Schedule of Investments:

•		The above investments with the exception of Rosbon, LLC are non-income producing. Equity investments that have not paid dividends within the last twelve months are considered non-income producing.
•		The value of all securities for which there is no readily available market value is determined in good faith by the Board of Directors. In making its determination, the Board of Directors has considered valuation appraisals provided by an independent valuation service provider. (See Notes 1 and 2 to the consolidated financial statements).
•		As of June 30, 2004, all of the securities that we own are subject to legal restrictions on resale. As a result, our ability to sell or otherwise transfer the securities we hold in our portfolio is limited.
•		We own more than 10% of the outstanding common stock of Image Analysis, Inc., Nubar, Inc., Clean Water Technologies, Inc., Rosbon LLC, Stealth MediaLabs, Inc., Circle Group Holdings, Inc., and Primapharm Funding Corporation.

See accompanying notes

Page 9 of 35

UTEK CORPORATION

Schedule of Investments
December 31, 2003

Page 10 of 35

Notes to Schedule of Investments:

•		The above investments with the exception of Rosbon, LLC are non-income producing. Equity investments that have not paid dividends within the last twelve months are considered non-income producing.
•		The value of all securities for which there is no readily available market value is determined in good faith by the Board of Directors. In making its determination, the Board of Directors has considered valuation appraisals provided by an independent valuation service provider. (See Notes 1 and 2 to the consolidated financial statements).
•		As of December 31, 2003, all of the securities that we own are subject to legal restrictions on resale. As a result, our ability to sell or otherwise transfer the securities we hold in our portfolio is limited.
•		We own more than 10% of the outstanding common stock of Image Analysis, Inc., Nubar, Inc., Clean Water Technologies, Inc., Rosbon LLC, Stealth MediaLabs, Inc., Circle Group Holdings, Inc., GloTech Industries, Inc. and Primapharm Funding Corporation.

See accompanying notes

Page 11 of 35

UTEK Corporation

Notes to Consolidated Financial Statements

(Information as of June 30, 2004 and 2003 and for the three and six month
periods then ended is unaudited)

1. Nature of Business and Significant Accounting Policies

Interim Financial Information

     The financial information for UTEK Corporation (the “Company”) as of June 30, 2004 and 2003 and for three and six month periods then ended is unaudited, but includes all adjustments (consisting only of normal recurring accruals) which, in the opinion of management are necessary in order to make the financial statements not misleading at such dates and for those periods. These financial statements have been prepared in accordance with the instructions for Form 10-Q and, therefore, do not include all information and footnotes required by accounting principles generally accepted in the United States. These consolidated financial statements should be read in conjunction with the consolidated audited financial statements and related notes included in the Company’s Form 10-K for the year ended December 31, 2003. Operating results for the three or six months ended June 30, 2004 are not necessarily indicative of the results that may be expected for the entire year.

     The Company

     We are a technology transfer company that assists companies in acquiring technologies from universities and federal research laboratories. Our business model generally involves two steps:

     • First, we form a strategic alliance and learn about the technologies that our client-companies need. We then find, acquire and finance new technologies for our client-companies from universities and research centers worldwide.

     • Second, we transfer the technologies to our client-companies in exchange for unregistered stock or cash.

     The result is an opportunity for our client-companies to grow and expand their intellectual capital. We call this process U2B^®.

     We are dedicated to building bridges between university-developed technologies and commercial organizations. We, along with our TechEx, UVentures and Techno-L on-line services and UTEK-Pax, Ltd. European subsidiary, identify and transfer new technologies from universities and research centers to the marketplace. We also provide research-outsourcing services to companies and technology-transfer services to research institutions.

     We focus on creating value for universities and laboratory research centers by facilitating the transfer of their intellectual capital to commercial partners. Our client-companies benefit from having the opportunity to acquire and commercialize new technologies primarily developed by universities, medical centers and federal research laboratories.

     We are a non-diversified, closed-end management investment company that has elected to be treated as a Business Development Company (“BDC”) under the Investment Company Act of 1940 (“1940 Act”).

     We commenced operations in 1997 as UTEK Corporation (“UTEK Florida”), which was incorporated under the laws of the State of Florida in August 1996. UTEK Florida was engaged in the business of technology transfer. On December 31, 1998, we formed UTEK, LLC, a limited liability company organized under the laws of the State of Florida. Subsequent thereto, the shareholders of UTEK Florida exchanged their shares of common stock for membership units in UTEK, LLC. In July 1999, we formed UTEK Corporation under the laws of the State of Delaware and in October 1999, UTEK LLC was merged into UTEK Corporation.

     In September 2001, UTEK Corporation acquired 100% of the outstanding common stock of UTEK-Pax Ltd. (formerly Pax Technology Transfer Ltd.), a United Kingdom corporation, in a stock for stock transaction. In May 2002, UTEK Corporation acquired 100% of the outstanding common stock of TechEx Acquisition Corporation (“TechEx”) in a stock for stock transaction. TechEx owned the TechEx.com website. The TechEx.com website, founded at Yale University, is used by many technology transfer and research professionals to efficiently exchange biomedical licensing opportunities and innovations available for partnering. The financial position and results of operation of UTEK-Pax Ltd. (formerly Pax Technology Transfer Ltd.) and Techex have been consolidated into the financial position and results of operation of the Company, since the dates of their respective acquisition.

Page 12 of 35

     In November 2003, UTEK Corporation acquired the UVentures.com website and certain other intellectual property assets from UVentures, Inc., an innovative Internet-based exchange primarily used for the marketing of physical science technologies developed at universities and research organizations.

     As a BDC, we must be primarily engaged in the business of furnishing capital and making available managerial assistance to companies that generally do not have ready access to capital through conventional financial channels. Such companies are termed “portfolio” companies.

     The Company invests in portfolio companies that management believes are positioned to benefit from the acquisition of new technology. The Company’s investments in portfolio companies generally are used by the portfolio companies to acquire the license rights to new technologies developed at universities and/or government research facilities. The Company offers to provide portfolio companies with managerial assistance primarily related to technology transfer. Technology transfer is the process by which technologies developed by universities or research laboratories are licensed to companies for commercial use. The Company also may make additional investments to fund continued research and development of the acquired technologies on behalf of its clients.

     Usually we have executed or will execute our investments in portfolio companies through the creation and capitalization of a wholly owned subsidiary company of UTEK, which we refer to as intellectual property acquisition company, to acquire a new technology. We will then seek to sell such intellectual property acquisition company to a company in a non-taxable exchange of shares. In connection with such transaction, we receive shares of common stock in the company (which company then becomes the portfolio company) in exchange for the securities of our intellectual property acquisition company. In addition to holding a license to a new technology, our intellectual property acquisition company may also hold cash and other assets. The companies which we engage in such transactions frequently have little or no prior operating history.

     To establish on-going consulting engagements with its clients, the Company has also developed a strategic alliance arrangement. UTEK’s strategic alliances are designed to help technology companies rapidly enhance their new product pipeline through the acquisition of proprietary intellectual capital from universities and federal laboratories. Some of our strategic alliance clients engage us to out-license their existing proprietary technologies.

Investments

     Pursuant to the requirements of the Investment Company Act of 1940 (the “1940 Act”), our Board of Directors is responsible for determining, in good faith, the fair value of our securities and assets for which market quotations are not readily available. In making its determination, the Board of Directors has considered valuation appraisals provided by an independent valuation service provider. With respect to equity securities in privately–owned companies, each investment is valued using industry valuation benchmarks, and then the value is assigned a discount reflecting the illiquid nature of the investment as well as our minority, non-control position. When an external event such as a purchase transaction, public offering, or subsequent equity sale occurs, the pricing indicated by the external event is used to corroborate our private equity valuation. Equity securities in public companies that carry certain restrictions on resale are generally valued at a discount from the market value of the securities as quoted on the a national securities exchange or by the national securities association. In addition, restricted and unrestricted publicly traded stocks may also be valued at further discounts due to the size of our investment or market liquidity concerns.

     The Board of Directors bases its determination upon, among other things, applicable quantitative and qualitative factors. These factors may include, but are not limited to, type of securities, nature of business, marketability, market price of unrestricted securities of the same issue (if any), comparative valuation of securities of publicly-traded companies in the same or similar industries, current financial conditions and operating results, sales and earnings growth, operating revenues, competitive conditions and current and prospective conditions in the overall stock market.

     Without a readily available market value, the value of our portfolio of equity securities may differ significantly from the values that would be placed on the portfolio if there existed a ready market for such equity securities. All equity securities owned at June 30, 2004 and December 31, 2003, (86.0% and 69.5% of net assets, respectively) are stated at fair value as determined by the Board of Directors, in the absence of readily available fair values. The Company uses the first-in, first-out (FIFO) method of accounting for sales of its investments.

Revenue Recognition

Sale Of Technology Rights

Page 13 of 35

     The Company recognizes revenue from the sale of technology rights upon the exchange of the shares of our intellectual property acquisition companies with companies (which companies then become our portfolio companies). The Company records revenue, based on the fair value as determined by the Board of Directors, of the consideration received. In most cases, the consideration received for the rights is unregistered shares of common stock of the portfolio company. The common stock received is recorded as an investment at fair value as determined by the Board of Directors.

Consulting and Other Services

     In addition to technology transfer transactions, we offer strategic alliance consulting services. A method of technology transfer already being used by UTEK-Pax Ltd. (formerly Pax Technology Transfer Ltd.), strategic alliance services are performed pursuant to service agreements (usually one year in length) in which UTEK provides consulting services by identifying and evaluating technology acquisition opportunities in exchange for unregistered shares of the company, or cash. These agreements are cancelable at any time.

     Revenues from strategic alliance agreements for which unregistered shares of common stock are received before they are earned are deferred and recognized over the term of each agreement. For strategic alliance agreements in which the stock is received ratably over the agreement, revenue is recognized as earned. The common stock received as payment is recorded as an investment at fair value as determined by the Board of Directors. In some cases the Company is paid a fee in connection with a technology transfer transaction. In these instances, revenue is recognized upon consummation of the transaction.

     The Company’s consolidated subsidiary, UTEK-Pax Ltd. (formerly Pax Technology Transfer Ltd.), derives its revenue primarily from consulting contracts with third parties. Revenue from consulting contracts is recognized ratably over the term of the contract, typically ninety days. These contracts are generally paid in the form of cash.

     Revenue from the sale of subscriptions to the TechEx.com and UVentures.com websites generally is received in the form of cash and initially is deferred and subsequently recognized ratably over the term of the subscription.

Foreign currency translation

     The Company translates the assets and liabilities of its non-U.S. functional currency subsidiary into dollars at the current rates of exchange in effect at the end of each reporting period. Revenues and expenses are translated using rates that approximate those in effect during the period. Translation adjustments are included in the Consolidated Balance Sheets under the caption “Foreign currency translation adjustment.”

Stock-Based Compensation

     At June 30, 2004, the Company had the following two stock-based equity compensation plans: the UTEK Corporation Amended and Restated Stock Option Plan and UTEK Corporation Amended and Restated Non-Qualified Stock Option Plan. The Company accounts for these plans and related grants thereunder using the intrinsic value method prescribed in APB Opinion No. 25, “Accounting for Stock Issued to Employees.” No stock-based employee compensation cost is reflected in net increase (decrease) in net assets from operations, as all of the options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on the net increase (decrease) in net assets from operations and the net increase (decrease) in net assets from operations per share if the Company had applied the fair value recognition provisions of SFAS 123, “Accounting for Stock-based Compensation” to the stock-based employee awards.

     The pro forma net increase (decrease) in net assets from operations and basic and diluted earnings per share for the three and six months ended June 30, 2004 and 2003 would have been as follows:

Page 14 of 35

During the quarter ended June 30, 2004, there were no options granted.

2. Investments

     Equity securities at June 30, 2004 and December 31, 2003 (86.0 % and 69.5% of net assets, respectively) were valued at fair value as determined by the Board of Directors, with the assistance of appraisals provided by an independent valuation service provider, in the absence of readily available market values.

     The values assigned to these securities are based upon available information and may not reflect amounts that could be realized if the Company found it necessary to immediately sell such securities, or amounts that ultimately may be realized. Accordingly, the fair values included in the accompanying schedule of investments may differ from the values that would have been used had a ready market existed for these securities and such differences could be significant.

     As of June 30, 2004 and 2003, the Company had established three and four intellectual property acquisition companies, respectively, which had $-0- net assets.

     On March 4, 2003, Peak Entertainment Holdings, Inc. (formerly Palladium Communications, Inc.) completed a 100 for 1 reverse split, which reduced the number of shares the Company holds to 4,000 from 400,000 shares.

     On March 18, 2003, the Company received 160,000 unregistered shares of common stock from Sequiam Corporation pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 160,000 shares.

     On March 26, 2003, the Company received 35,294 unregistered shares of common stock from Graphco Technologies, Inc. pursuant to strategic alliance agreement. The Company has recognized consulting fees to date relating to 35,294 shares.

     On March 26, 2003, the Company received 821,429 unregistered shares of common stock from Circle Group Holdings, Inc. in connection with an assignment of a technology license.

     On June 17, 2003, the Company received 34,000 unregistered shares of common stock from E Med Future, Inc. pursuant to strategic alliance agreement. The Company has recognized consulting fees to date relating to 34,000 shares.

     On June 23, 2003, the Company sold its Advanced Illumination Technologies, Inc. intellectual property acquisition company to GloTech Industries, Inc., (now known as Intra-Asia Entertainment Corp.) for 1,000,000 unregistered shares of GloTech Industries, Inc.’s common stock in a non-taxable exchange.

     On July 23, 2003, the Company received 130,208 unregistered shares of common stock from Circle Group Holdings, Inc. in connection with an assignment of a technology license.

     On August 28, 2003, the Company sold its Sports Technologies, Inc. intellectual property acquisition company to GloTech Industries, Inc., (now known as Intra-Asia Entertainment Corp.) for 2,130,000 unregistered shares of GloTech Industries, Inc.’s common stock in a non-taxable exchange.

     On September 10, 2003, the Company sold its Fingerprint Detection Technologies, Inc. intellectual property acquisition company to Sequiam Corporation for 485,000 unregistered shares of Sequiam Corporation’s common stock in a non-taxable exchange.

     On December 3, 2003, the Company received 545,000 unregistered shares of common stock from Magic Media Networks, Inc. pursuant to a six-month strategic alliance agreement. The Company has recognized consulting fees to date relating to 545,000 shares.

Page 15 of 35

     On December 10, 2003, the Company received 240,000 unregistered shares of common stock from AssureTec Holdings, Inc. pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 60,000 shares

     On December 30, 2003, the Company sold its Medical Safety Technologies, Inc. intellectual property acquisition company to E Med Future, Inc. for 1,250,000 unregistered shares of E Med Future, Inc.’s common stock in a non-taxable exchange.

     On January 26, 2004, the Company received 30,000 unregistered shares of common stock from GeneThera, Inc. pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 14,394 shares.

     On February 18, 2004, the Company received 38,585 unregistered shares of common stock from Telkonet, Inc. pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 14,190 shares.

     On February 17, 2004, the Company received 705,882 unregistered shares of common stock from ZKid Network Company pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 281,745 shares.

     On March 12, 2004, the Company received 100,000 unregistered shares of common stock from Health Sciences Group, Inc. pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 33,332 shares.

     On March 29, 2004, the Company received 200,000 unregistered shares of common stock from Swiss Medica, Inc. pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 103,835 shares.

     On March 30, 2004, the Company entered into a strategic alliance agreement with eFoodSafety.com, Inc. The agreement provides for a total of 244,987 unregistered shares of eFoodSafety.com, Inc.’s common stock to be distributed to the Company pro rata during the term of the agreement. The Company has received 81,632 and recognized to date consulting fees in relation to 68,261 unregistered shares of eFoodSafety.com, Inc.

     On April 1, 2004, the Company received 63,157 unregistered shares of common stock from Xethanol Corporation pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 15,789 shares.

     On April 5, 2004, the Company received 150,000 unregistered shares of common stock from Manakoa Services Company pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 35,416 shares.

     On April 16, 2004, the Company received 240,000 unregistered shares of common stock from Power3 Medical Products, Inc. pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 49,333 shares.

     On April 23, 2004, the Company received 133,333 unregistered shares of common stock from The Jenex Corporation pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 74,443 shares.

     On April 28, 2004, the Company received 400,000 unregistered shares of common stock from HydroFlo Corporation pursuant to a strategic alliance agreement. The Company has recognized consulting fees to date relating to 68,888 shares.

     On April 30, 2004, the Company sold its Web Safe Technologies, Inc. intellectual property acquisition company to ZKid Network Company for 9,550,000 unregistered shares of ZKid Network Company’s common stock in a non-taxable exchange.

     On June 25, 2004, the Company sold its Advanced Bioethanol Technologies, Inc. intellectual property acquisition company to Xethanol Corporation for 200,000 unregistered shares of Xethanol Corporation’s common stock in a non-taxable exchange.

3. Commitments and Contingencies

     From time to time, some of the Company’s portfolio companies may receive correspondence or other notices of alleged breach of the license agreement. Some of these correspondences and notices provide for a period of time in which to cure the alleged breach. The failure of the portfolio companies to cure the alleged breach may have a material adverse impact on their value and as a result on the Company’s results of operations and financial position.

     Effective September 1, 1999, the Company entered into a five year employment agreement with its CEO providing for an annual base salary of $150,000 for his services.

4. Valuations

Page 16 of 35

     The Board of Directors bases its determination of fair value upon, among other things, applicable quantitative and qualitative factors. These factors may include, but are not limited to, type of securities, nature of business, marketability, market price of unrestricted securities of the same issue (if any), comparative valuation of securities of publicly-traded companies in the same or similar industries, current financial conditions and operating results, sales and earnings growth, operating revenues, competitive conditions and current and prospective conditions in the overall stock market.

5. Subsequent Events

     Circle Group Holdings, Inc. represented 71.4% of our net assets at the quarter ended June 30, 2004. On August 4, 2004, the $2.06 market closing price per share of Circle Group Holdings, Inc. on the American Stock Exchange represented a decrease of 60% from the $5.15 market closing price per share on the American Stock Exchange on June 30, 2004. This decline in the market value of Circle Group Holdings, Inc. will have a material negative impact on UTEK’s financial condition from that reported for the period ended June 30, 2004. Management estimates that, based on this decline in market price for Circle Group Holdings, Inc., the Company’s net asset value per share would decrease by approximately $1.13 per share or 27% from the net value per share reported at June 30, 2004.

     On August 2, 2004, under its Strategic Alliance Agreement with the Shriner’s Hospitals for Children (Shriners), the Company facilitated the technology-transfer to Crystal Point Partners of a Shriners’ developed biomaterial for tendon and ligament reconstruction. As the success fee for this transaction, the Company will receive ten percent of Tendon and Ligament, Inc., a new company formed by Crystal Point Partners to commercialize the Shriners’ Technology. The Company has not yet determined the value of its equity stake in Tendon and Ligament, Inc.

     On August 3, 2004, Arsenic Removal Technologies, Inc., a wholly owned subsidiary of UTEK Corporation acquired the worldwide exclusive license to a technology for the removal of water-soluble forms of arsenic from water utilizing a compound developed by researchers at the Department of Renewable Resources at the University of Wyoming, HydroFlo, Inc. has acquired Arsenic Removal Technologies, Inc. (ARTI), a wholly owned subsidiary of UTEK Corporation, in a stock transaction. In connection with the sale, we received 3,200,000 shares of unregistered shares of common stock of HydroFlo, Inc. with a fair value of approximately $400,000.

     On August 4, 2004, Advanced Cyber Security, Inc., a wholly owned subsidiary of UTEK Corporation acquired the worldwide exclusive license to the prototype software system called Systems Administrator Simulation Trainer (SAST). Manakoa Services Corporation has acquired Advanced Cyber Security, Inc. (ACSI), a wholly owned subsidiary of UTEK Corporation, in a stock transaction. In connection with the sale, we received 2,000,000 shares of unregistered shares of common stock of Manakoa Services Corporation, with a fair value of approximately $500,000.

Page 17 of 35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion should be read in conjunction with our financial statements and the notes thereto included elsewhere in this Form 10-Q. This Form 10-Q contains forward-looking statements regarding the plans and objectives of management for future operations. This information may involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and we cannot assure you that these projections included in these forward-looking statements will come to pass. Our actual results could differ materially from those expressed or implied by the forward-looking statements as a result of various factors.

Critical Accounting Policies and Estimates

     The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Critical accounting policies are those that are both important to the presentation of our financial condition and results of operations and require management’s most difficult, complex, or subjective judgments. Our most critical accounting policy relates to the valuation of our investments.

     Pursuant to the requirements of the Investment Company Act of 1940 (the “1940 Act”), our Board of Directors is responsible for determining in good faith the fair value of our investments for which market quotations are not readily available. Although the securities of many of our portfolio companies are quoted on the OTC Bulletin Board or listed on the American Stock Exchange, our Board of Directors is required to determine the fair value of such securities if the validity of the market quotations appears to be questionable, or if the number of quotations is such as to indicate that there is a thin or illiquid market in the security.

     We determine fair value to be the amount for which an investment could be exchanged in an orderly disposition over a reasonable period of time between willing parties other than in a forced or liquidation sale. Our valuation policy considers the fact that no ready market exists for substantially all of the securities in which we invest. Our valuation policy is intended to provide a consistent basis for determining the fair value of the portfolio. We will record unrealized depreciation on investments when we believe that an investment has become impaired, including where realization of an equity security is doubtful. We will record unrealized appreciation if we believe that the underlying portfolio company has appreciated in value and, therefore, our equity security has also appreciated in value.

     Our equity interests in portfolio companies for which there is no liquid public market are valued using industry valuation benchmarks, and then the value is assigned a discount reflecting the illiquid nature of the investment as well as our minority, non-control position. When an external event such as a purchase transaction, public offering, or subsequent equity sale occurs, the pricing indicated by the external event is used to corroborate our valuation. The determined values are generally discounted to account for restrictions on resale and minority ownership positions.

     The value of our equity interests in public companies for which market quotations are readily available is based on the public market price on the balance sheet date. Securities that carry certain restrictions on resale are typically valued at a discount from the public market value of the security.

General

     Our primary investment objective is to increase our net assets by exchanging stock in new companies that we form to acquire intellectual property, which we refer to as an “intellectual property acquisition company,” for cash and other assets upon the completion of technology transfer transactions. We seek to achieve our investment objective by creating intellectual property acquisition companies to identify, license and market new technologies invented primarily by employees of universities and federal research laboratories. We intend to sell our intellectual property acquisition companies principally to privately owned and publicly traded companies (which we refer to as “portfolio companies” or our “investments”) in tax-free stock for stock exchanges. It is our plan that shares of those privately owned and publicly traded companies received in those exchanges will, in the course of our business, be sold for cash or other assets to permit us to acquire additional technologies and to fund our

Page 18 of 35

operations. We seek to sell our intellectual property acquisition companies into publicly traded portfolio companies whenever possible, as this provides us with the potential for added liquidity.

     To facilitate establishing on-going consulting engagements with our clients, we have developed a strategic alliance process. Our strategic alliances are designed to help technology companies enhance their new product pipeline through the acquisition of proprietary intellectual capital primarily from universities and federal laboratories. We normally receive unregistered shares of common stock from our clients as payment for the services we render under our strategic alliance consulting engagements. Whenever possible, we will seek to receive cash payments as compensation for our services.

     Our expenses include salaries and wages, professional fees, sales and marketing costs as well as general and administrative costs. Sales and marketing costs include license and sponsored research fees, as well as advertising, commissions, travel and other expenses that vary with revenues. General and administrative costs include rent, depreciation, office, investor relations and other overhead costs.

Financial Condition

          The Company’s total assets were $28,469,049 and its net assets were $23,161,426 at June 30, 2004, compared to $12,549,448 and $11,152,370 at December 31, 2003, respectively. Net asset value per share (“NAV”) was $4.22 at June 30, 2004 and $2.33 at December 31, 2003.

     Net assets increased by $12,009,056 in the six months ended June 30, 2004 and decreased by $(2,029,877) in the six months ended June 30, 2003.

     The changes in total assets, net assets and net asset value during the three months ended June 30, 2004 were primarily attributable to:

•

An unrealized depreciation on investments of approximately $2.4 million, mainly due to the decrease in the value of our investment in Circle Group Holdings, Inc. Circle Group makes up over 70% of our investment portfolio at value

•

The sale of some investments for approximately $780,000.

•

The use of approximately $1.4 million in cash to fund our operations.

•

The issuance of common stock in private placement transactions and upon the exercise of stock options of approximately $1.3 million.

•

Two technology transfers valued at approximately $1.4 million.

     The changes in total assets, net assets and net asset value during the three months ended June 30, 2003 were primarily attributable to:

•

One technology transfer valued at approximately $300,000 and strategic alliance agreements and other consulting agreements with earned revenue of approximately $304,000.

•

An increase of approximately $600,000 in the value of the Company’s investments.

•

The issuance of common stock in private placement transactions and proceeds from a loan, net of expenses and prepaid interest, of $1.7 million

•

The use of approximately $700,000 in cash to fund our operations.

     The Company’s common shares outstanding as of June 30, 2004 were 5,488,386, compared to 4,790,550 at December 31, 2003. The number of common shares increased as a result of the completion of private placement transactions as well as the issuance of common shares upon the exercise of employee stock options that were exercised during the quarter ended June 30, 2004.

     The Company’s financial condition is dependent on a number of factors including the ability to effectuate technology transfers transactions and the performance of the equity investments that we receive for these transfers. The Company has invested a substantial portion of its assets in private development stage or start-up companies. These private businesses are thinly capitalized, unproven, small companies that lack management depth, are dependent on new, commercially unproven technologies and have no history of operations.

     At June 30, 2004, $19,193,036 or 96% of our investments consisted of equity securities at fair value in thinly traded public companies and $770,479 or 4% of our investments consisted of equity securities at fair value in private companies.

Page 19 of 35

     At December 31, 2003, $7,661,264 or 99% of our investments consisted of equity securities at fair value in thinly traded public companies and $84,090 or 1% of our investments consisted of equity securities at fair value in private companies.

     The net increase in the value of investment securities from $7,745,354 to $19,963,515 in the six months ended June 30, 2004 is primarily due to the following events:

•

The Company exercised warrants to purchase 500,000 shares of common stock of Circle Group Holdings, Inc. for $180,000 with a fair value of $2,115,000.

•

The Company entered into eleven new strategic alliance agreements that generated $1 million in value.

•

The Company sold 388,892 of its shares in Circle Group Holdings, Inc. for $2.2 million with a fair value of $1 million.

•

The Company completed two sales of technology rights valued at $1.4 million

•

The Company experienced an overall increase in the value of its public company securities. This increase is primarily attributable to an increase in the value of Circle Group Holdings, Inc. of approximately $8.6 million. The Company’s other investments experienced a net decrease in their fair value of approximately $134,000. The Company’s investments can decrease due to factors that are specific to these investments (inability to obtain additional capital, inability to execute their business model, termination of their technology licenses, etc.) or to general marketplace factors.

     A summary of the Company’s investment portfolio is as follows:

Results of Operations

     The principal measure of our financial performance is the “Net increase in net assets from operations” which is the sum of three elements. The first element is “Net income from operations,” which is the difference between our income from technology transfer transactions, consulting fees, interest income, dividends, fees and other income and our operating expenses, net of applicable income tax provision. The second element is “Net realized gain (loss) on investments,” which is the difference between the proceeds received from dispositions of portfolio securities and their stated cost, net of applicable income tax provision. The third element, “Increase (decrease) in unrealized appreciation on investments,” is the net change in the fair value of the Company’s investment portfolio, net of increase (decrease) in deferred income taxes that would become payable if the unrealized appreciation were realized through the sale or other disposition of the investment portfolio.

Three months ended June 30, 2004 compared to the three months ended June 30, 2003.

     Income from operations. Income from operations increased 217% to $1,925,587 for the three months ended June 30, 2004 from $606,635 for the three months ended June 30, 2003. Approximately 86% and 61% of our income from operations (revenue) was received in the form of equity securities for the three months ended June 30, 2004 and June 30, 2003, respectively. The increase in income from operations resulted from completing two sales of technology rights valued at $1,406,300, which was received in the form of common stock, during the period ended June 30, 2004, as compared to one sale of technology rights valued at $300,000, which was received in the form of common stock, completed during the quarter ended June 30, 2003. In the three months ended June 30, 2004, we rendered services in connection with eighteen strategic alliance agreements (seven of which began in the three months ended June 30, 2004) valued at $311,874, as compared to seven strategic alliance agreements (three of which began during the quarter ended June 30, 2003) valued at $149,492. Other services including income of $148,496 generated from UTEK-Pax Ltd., (formerly known as Pax Technology Transfer, Ltd.) and subscription income from the two websites owned by UTEK comprise the balance of consulting fees. Our Board of Directors determines the fair value of the shares we receive in the absence of readily determinable market values. In making its determination, the Board of Directors has considered valuation appraisals provided by an independent valuation service provider.

     Expenses. Total operating expenses for the three months ended June 30, 2004 were $1,375,658, consisting of salaries and wages of $334,086, professional fees of $157,045, sales and marketing expenses of $451,504, and general and administrative expenses of $433,023. These expenses compared to the $699,909 reported for the three months ended June 30, 2003, consisting of salaries and wages of $164,104, professional fees of $122,149, sales and marketing expenses of $97,102, and general and administrative expenses of $316,554. The 97% increase in total operating expenses was due to the increased costs of completing

Page 20 of 35

two technology transfer transactions, an increase in the number of our sales personnel, a bonus for the CEO of the Company, extended marketing efforts and investor relations services provided by a third party vendor. The 103% increase in salaries and wages reflects a bonus paid to the CEO in the second quarter. The 365% increase in sales and marketing expenses was due to the increased costs of completing two sales of technology rights, an increase in the number of our sales personnel, commissions to outside service providers used strictly to generate strategic alliance agreements and an extended marketing effort at various conferences in order to increase the number of potential strategic alliance customers. The 28% increase in professional fees is due to the timing of the audit fees offset partially by reduced costs in legal fees. The 37% increase in general and administrative costs is due to the cost of investor and public relations services provided by a third party vendor that were not provided in 2003 and an increase in the number of temporary staff, an increase in payroll taxes related to an increase in staff, and increased printing costs for producing our annual report.

     Income from operations can vary substantially on a quarterly basis due to the small number and wide range of value of the transactions. Therefore, quarterly income from operations should not be annualized to predict expected annual results.

     Net Realized Gains (Losses)

     Net realized gains on investments net of income tax effect amounted to $914,683 for the three months ended June 30, 2004 and were related to sales as follows:

     Net realized losses on investments net of income tax effect amounted to $168,511 for the three months ended June 30, 2003 and were related to sales as follows:

     On a quarterly basis, net realized gains and losses can vary substantially, due to a variety of factors. Therefore, quarterly net realized gains and losses should not be annualized to predict expected annual results, and may not be indicative of future performance.

Six months ended June 30, 2004 compared to the six months ended June 30, 2003.

          Income from operations. Income from operations increased 110% to $2,335,686 for the six months ended June 30, 2004 from $1,110,906 for the six months ended June 30, 2003. The increase in income from operations resulted from completing two sales of technology rights with greater value than the two transactions for the six months ended June 30, 2003. As described below, in the six months ended June 30, 2004 we completed two sales of technology rights valued at $1,406,300, compared to two sales of technology rights valued at $562,857 for the six months ended June 30, 2003. During the six months ended June 30, 2004, we completed sales of technology rights transactions with Xethanol Corporation in which we received 200,000 shares of common stock of that were valued at $2.50 per share and with Zkid Network Company in which we received 8,550,000 of unregistered shares of common stock of that were valued at $.106 per share. In the six months ended June 30, 2004, we rendered services in connection with eighteen strategic alliance agreements valued at $497,260, as compared to seven strategic alliance agreements valued at $249,955 for the six months ended June 30,2003. Other services including income of $342,927 from UTEK-Pax Ltd., (formerly known as Pax Technology Transfer, Ltd.) and subscription income from the two websites owned by UTEK comprise the balance of the consulting fees. Our Board of Directors determines the fair value of the shares we receive in the absence of readily available market values. In making its determination, the Board of Directors has considered valuation appraisals provided by an independent valuation service provider.

          Expenses. Total operating expenses for the six months ended June 30, 2004 were $2,225,926 consisting of salaries and wages of $511,144, professional fees of $245,194, sales and marketing expenses of $678,461, and general and administrative expenses of $791,127. These expenses compared to the $1,515,257 reported for the six months ended June 30, 2003, consisting of salaries and wages of $341,416, professional fees of $383,010, sales and marketing expenses of $188,566, and general and

Page 21 of 35

administrative expenses of $602,265. The 90% increase in total operating expenses was due to an increased number of employees, increased costs of completing sales of technology rights, commissions to outside service providers used strictly to generate strategic alliance agreements and an extended marketing effort at various conferences in order to increase the number of potential strategic alliance customers, increased costs related to investor and public relations, a bonus paid to the CEO of the Company, and increased use of temporary personnel. It is our intention to continue to grow our sales force by increasing the number of sales personnel in locations around the United States, Europe and Canada. The 50% increase in salaries and wages reflects an increase in the number employees in the second quarter as well as a bonus to the CEO of the Company. The 260% increase in sales and marketing expenses was due to increased costs related to the two sales of technology rights, commissions to outside service providers used strictly to generate strategic alliance agreements and an extended marketing effort at various conferences in order to increase the number of potential strategic alliance customers, and an increase in the number of sales personnel. The 36% decrease in professional fees is largely due a significant decrease in accounting fees, professional fees that were associated with a specific first quarter project in 2003 that were not repeated in 2004, as well as a decrease in legal fees. The 31% increase in general and administrative costs is largely due to the cost of investor and public relations services provided by third party vendors that were not provided in 2003, an increase in the number of temporary staff, an increase in payroll taxes related to an increase in employees, and the increased printing costs of producing our annual report We do not see a continued increase in these overhead costs as the Company has discontinued the use at this time of temporary help and the outside public relations firm.

          Income from operations can vary substantially on a quarterly basis due to the small number and wide range of value of the transactions. Therefore, quarterly income from operations should not be annualized to predict expected annual results.

     Net Realized Gains (Losses)

     Net realized gains on investments net of income tax effect amounted to $1,266,711 for the six months ended June 30, 2004 and were related to sales as follows:

     Net realized losses on investments net of income tax effect amounted to $175,440 for the six months ended June 30, 2003 and were related to sales as follows:

     On a quarterly basis, net realized gains and losses can vary substantially, due to a variety of factors. Therefore, quarterly net realized gains and losses should not be annualized to predict expected annual results, and may not be indicative of future performance.

Changes in Unrealized Appreciation or Depreciation.

     We determine the value of each investment in our portfolio on a quarterly basis, and changes in value result in unrealized appreciation or depreciation being recognized. At June 30, 2004, approximately 96% of our net assets represented investments recorded at fair value. Value, as defined in Section 2(a)(41) of the 1940 Act, is (i) the market price for those securities for which a market quotation is readily available and (ii) for all other securities and assets, fair value is as determined in good faith by the board of directors. Although many of the securities we hold in our portfolio are quoted on the OTC Bulletin Board or listed on the American Stock Exchange, our Board of Directors is required to fair value price such securities if the validity of the market quotations appears to be questionable, or if the number of quotations is such as to indicate that there is a thin market in the security. Since there is typically no readily available market value for the investments in our portfolio, we value

Page 22 of 35

substantially all of our investments at fair value as determined in good faith by the Board of Directors. In making its determination, our Board of Directors may consider valuation appraisals provided by independent valuation service providers. Because of the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments determined in good faith by the Board of Directors may differ significantly from the values that would have been used had a ready market existed for the investments, and the differences could be material.

     There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. We will record unrealized depreciation on investments when we believe that an investment has become impaired, including where realization of an equity security is doubtful. Conversely, we will record unrealized appreciation if we have an indication that the underlying portfolio company has appreciated in value and, therefore, our equity security has also appreciated in value, where appropriate.

     Our equity interests in portfolio companies for which there is no liquid public market are valued using industry valuation benchmarks, and then the value is assigned a discount reflecting the illiquid nature of the investment as well as our minority, non-control position. When an external event such as a purchase transaction, public offering, or subsequent equity sale occurs, the pricing indicated by the external event is used to corroborate our private equity valuation. The determined values are generally discounted to account for restrictions on resale and minority ownership positions.

     The value of our equity interests in public companies for which market quotations are readily available is based on the public market price. Securities that carry certain restrictions on resale are typically valued at a discount from the public market value of the security.

     The Board of Directors bases its determination upon, among other things, applicable quantitative and qualitative factors. These factors may include, but are not limited to, type of securities, nature of business, marketability, market price of unrestricted securities of the same issue (if any), comparative valuation of securities of publicly-traded companies in the same or similar industries, current financial conditions and operating results, sales and earnings growth, operating revenues, competitive conditions and current and prospective conditions in the overall stock market.

     We have retained Bolten Financial Consulting, Inc. to provide us with quarterly valuations of our portfolio of equity securities.

     The net unrealized depreciation on our investments, net of taxes, increased by $1,469,070 for the three months ended June 30, 2004, compared to net unrealized appreciation of $885,061 on our investments for the three months ended June 30, 2003. The net unrealized appreciation and depreciation consisted of fluctuations in fair value resulting from the Board of Directors’ valuation of the Company’s assets for the three months ended June 30, 2004 and 2003, respectively. There was a significant decrease in value in the three months ended June 30, 2004 in our investment in Circle Group Holdings, Inc., as well as minor decreases in some of our other investments. However, this was offset slightly by an increase in appreciation related to our investments in Duraswitch Industries, Inc., Intra-Asia Entertainment Corp. (formerly GloTech Industries, Inc.), AssureTec Holdings Inc. and eFoodSafety.com, Inc.

     The Company’s most significant portfolio investment is in Circle Group Holdings, Inc., which represented 71.4% of our net assets in the quarter ended June 30, 2004. The following is a simplified summary of the methodology that we used to determine the fair value of this investment.

     At June 30, 2004, the fair value of our investment in Circle Group was approximately $16.5 million. The value of our investment in Circle Group decreased by approximately $2.1 million before tax effect for the quarter ended June 30, 2004. Approximately 28% of the decrease was a result of the sale of shares in the open market. The remaining decrease in the value of our investment in Circle Group resulted from our Board of Directors determination that our investment in Circle Group had depreciated by 114% because of a decrease in the market price of shares of common stock of Circle Group. The Board of Directors determined that market quotations for shares of common stock of Circle Group on the American Stock Exchange are readily available. As a result, the Board of Directors took the closing market price for a share of common stock of Circle Group on the American Stock Exchange as of the balance sheet date and then discounted such market price to take in account that the shares of common stock of Circle Group that the Company holds are subject to legal restrictions on resale.

     On a quarterly basis net unrealized appreciation and depreciation can vary substantially, due to a variety of factors. Therefore, quarterly net unrealized appreciation and depreciation should not be annualized to predict expected annual results, and may not be indicative of future performance.

Liquidity and Capital Resources

Page 23 of 35

     Net assets increased 108% to $23,161,426 at June 30, 2004 from $11,152,370 at December 31, 2003. This increase was primarily attributable to the completion of private placement transactions totaling $3.1 million during the six months as well as net realized gains of approximately $1.3 million, and the $6.3 million increase in the net unrealized appreciation in the value of our non-controlled affiliate investments.

     Our primary sources of liquidity and capital for the three months ended June 30, 2004 was from cash received from private placement transactions totaling $3.5 million as well as from the sales of our investments totaling approximately $2.3 million .

     In January 2004, we completed two private placements for 407,986 shares of our common stock at $7.00 per share. The purchasers of the shares of common stock agreed not to sell or otherwise transfer the shares for a period of one-year after the completion of the private placement transaction. The total net proceeds received inclusive of the December receipts of $388,412 was $2,570,312, net of investment banking fees of $285,590.

     In January 2004, we repaid the loan we obtained in April 2003 by issuing 125,715 shares of our common shares to the lender. The balance owed at the time the shares were issued was $880,000. The shares were issued at an effective value of $7.00 per share.

     In April 2004, the Company completed a private placement transaction with accredited investors of 100,000 shares of its common stock at $10.00 per share. The purchasers of the shares of common stock agreed not to sell or otherwise transfer the shares for a period of one-year after the completion of the private placement transaction. The net proceeds after investment banking fees of $100,000 was $900,000.

Recent Developments

     Circle Group Holdings, Inc. represented 71.4% of our net assets at the quarter ended June 30, 2004. On August 4, 2004, the $2.06 market closing price per share of Circle Group Holdings, Inc. on the American Stock Exchange represented a decrease of 60% from the $5.15 market closing price per share on the American Stock Exchange on June 30, 2004. This decline in the market value of Circle Group Holdings, Inc. will have a material negative impact on UTEK’s financial condition from that reported for the period ended June 30, 2004. Management estimates that, based on this decline in the market price for Circle Group Holdings, Inc., the Company’s net asset value per share would decrease by approximately $1.13 per share or 27% from the net asset value per share reported at June 30, 2004.

     On August 2, 2004, under its Strategic Alliance Agreement with the Shriner’s Hospitals for Children (Shriners), the Company facilitated the technology-transfer to Crystal Point Partners of a Shriners’ developed biomaterial for tendon and ligament reconstruction. As the success fee for this transaction, the Company will receive ten percent of Tendon and Ligament, Inc., a new company formed by Crystal Point Partners to commercialize the Shriners’ technology. The Company has not yet determined the value of its equity stake in Tendon and Ligament, Inc.

     On August 3, 2004, Arsenic Removal Technologies, Inc., a wholly owned subsidiary of UTEK Corporation acquired the worldwide exclusive license to a technology for the removal of water-soluble forms of arsenic from water utilizing a compound developed by researchers at the Department of Renewable Resources at the University of Wyoming. HydroFlo, Inc. has acquired Arsenic Removal Technologies, Inc. (ARTI), a wholly owned subsidiary of UTEK Corporation in a stock transaction. In connection with the sale, we received 3,200,000 shares of unregistered shares of common stock of HydroFlo, Inc. with a fair value of approximately $400,000.

     On August 4, 2004, Advanced Cyber Security, Inc., a wholly owned subsidiary of UTEK Corporation acquired the worldwide exclusive license to the prototype software system called Systems Administrator Simulation Trainer (SAST). Manakoa Services Corporation has acquired Advanced Cyber Security, Inc. (ACSI), a wholly owned subsidiary of UTEK Corporation, in a stock transaction. In connection with the sale, we received 2,000,000 shares of unregistered shares of common stock of Manakoa Services Corporation, with a fair value of approximately $500,000.

Risk Factors

               Investing in the Company involves a number of significant risks relating to its business and investment objective. As a result, there can be no assurance that the Company will achieve its investment objective. In addition to the risk factors described below, other factors that could cause actual results to differ materially include:

•

changes in the economy;

•

risk associated with possible disruption in the Company’s operations due to terrorism;

•

future regulatory actions and conditions in the Company’s operating areas; and

•

other risks and uncertainties as may be detailed from time to time in the Company’s public announcements and SEC filings.

Our financial results are largely dependent upon the performance of Circle Group Holdings, Inc.

Our financial results are largely dependent upon the performance of Circle Group Holdings, Inc. As of June 30, 2004, the value of our investment in Circle Group Holdings, Inc. was approximately $16.5 million or 71.4% of our net assets.

Our quarterly and annual results could fluctuate significantly.

Our quarterly and annual operating results could fluctuate significantly due to a number of factors. These factors include the small number and range of values of the transactions that are completed each quarter, fluctuations in the values of our investments, the timing of the recognition of unrealized gains and losses, the degree to which we encounter competition in our markets, the volatility of the stock market and its impact on our unrealized gains and losses, as well as other general economic conditions. As a result of these factors, quarterly and annual results are not necessarily indicative of our performance in future quarters and years.

Our investment model is highly speculative in nature and our history of using the model is limited.

Our investment model is highly speculative since it involves making investments in new development stage companies and having those companies invest in new, untested technology. Furthermore, we have only been using our investment model for a relatively short period of time and have little or no historical information upon which to judge whether or not the model is successful. We cannot assure you that our investment model will be successful or that any of our investments will be successful.

Page 24 of 35

Our portfolio companies are development stage companies dependent upon the successful commercialization of new technologies. Each of our investments in portfolio companies is subject to a high degree of risk and we may lose all of our investment in a portfolio company if it is not successful.

We invest in development stage companies that our management believes can benefit from our expertise in technology transfer. Development stage companies are subject to all of the risks associated with new businesses. In addition, our portfolio companies are also subject to the risks associated with research and development of new technologies. These risks include the risk that new technologies cannot be identified, developed or commercialized, may not work, or become obsolete. Our portfolio companies must successfully acquire licenses to new technologies, and in some cases further develop new technologies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies will be competing with larger, established companies, with greater access to, and resources for, further development of these new technologies. We may lose our entire investment in any or all of our portfolio companies.

Our portfolio companies depend upon the research and development activities of universities and research laboratories, over which neither our portfolio companies nor we have any control.

Our portfolio companies depend upon the research activities of universities and government research facilities. Neither we, nor our portfolio companies, have any control over the research activities of universities and research laboratories. As neither we, nor our portfolio companies provide supervision of any university or laboratory research, we cannot warrant that the research will be done properly and that the results, which we may license will be reproducible. In addition, we have no control over what types of research are presented to us by universities and government research facilities for evaluation and commercial development. Further, the licenses to technologies that our portfolio companies obtain may be non-exclusive.

Technologies acquired by our portfolio companies may become obsolete before we can sell their securities.

Neither our portfolio companies nor we have any control over the pace of technology development. There is a significant risk that a portfolio company could acquire the rights to a technology that is currently or is subsequently made obsolete by other technological developments. We cannot assure you that any of our portfolio companies will successfully acquire, develop and transfer any new technology.

The patents on the technologies that our portfolio companies license may infringe upon the rights of others and patent applications that the universities have submitted may not be granted.

Many of our portfolio companies rely upon patents to protect the technologies that they license. If the patents on technologies that they license are found to infringe upon the rights of others, or are held to be invalid, then the licenses to such technologies will have little or no value to our portfolio companies. In addition, if a patent licensed by a portfolio company is found to infringe upon the rights of others, the portfolio company may be liable for monetary damages. Our portfolio companies are dependent upon the universities or government research facilities to file, secure and protect patents on licensed technologies. In the event that a patent is challenged or violated, our portfolio companies may not have the financial resources to defend the patent either in the preliminary stages of litigation or in court. In addition, if our portfolio companies acquire licenses to technologies with patents pending, we cannot assure you that such patents will be granted.

Technologies that have been developed with funding from the United States government may have limits on their use, which could affect the value of the technology to a portfolio company.

Technologies developed with funds provided by the United States government have restrictions regarding where they may be sold and have limits on exclusivity. A portfolio company that acquires a technology developed with federal funding may be limited as to where it can sell the technology. The technology may only be allowed to be sold or manufactured within the United States. In addition, the U.S. government has the right to use technologies that it has funded regardless of whether the technology has been licensed to a third party. Such regulations may limit the marketability of a technology and therefore reduce the value of the technology to our portfolio companies.

We may need to make additional cash investments in our portfolio companies to provide them with capital to further develop licensed technologies.

We may have to make additional cash investments in our portfolio companies to protect our overall investment value in the particular company. We retain the discretion to make any additional investments as our management determines. The failure to make such additional investments may jeopardize the continued viability of a portfolio, and our initial (and subsequent) investments. Moreover, additional investments may limit the number of companies in which we can make initial investments. We have no established criteria in determining whether to make an additional investment except that our management will exercise its business judgment and apply criteria similar to those used when making the initial investment. We cannot assure

Page 25 of 35

you that we will have sufficient funds to make any necessary additional investments, which could adversely affect our success and result in the loss of a substantial portion or all of our investment in a portfolio company.

We may be unable or decide not to make additional investments in our portfolio companies which could result in our losing our initial investment if the portfolio company fails. Our ownership and control may be diluted if a portfolio company obtains additional funds from third-party investors.

Our agreement with third-party investors restricts the size of our investment in any single portfolio company and, as a result, could prohibit an additional investment in a portfolio company in the event that our initial investment represented 10% or more of our assets. Even if we are able to make an additional investment in a portfolio company within the prescribed limits, we may elect not to make an additional investment in a portfolio company in order to limit the size of our investment, which is at risk. It is also our policy not to make loans to our portfolio companies that in the aggregate exceed 25% of our net assets. Therefore, if a portfolio company requires additional funds to continue operating, and we cannot or choose not to make an additional investment, our investment in the portfolio company may decline in value. In addition, to the extent that a portfolio company seeks additional financing from third parties, our ownership interest and control of the portfolio company may be diluted.

The securities we hold in our portfolio companies are subject to restriction on resale and we may not be able to sell the securities we hold for amounts equal to their recorded value, if at all.

Our portfolio companies are mainly private entities or thinly traded public companies and we acquire securities in our portfolio company in private transactions. As a result, all of the securities we hold in our portfolio companies are subject to legal restrictions on resale. Furthermore, our ability to sell the securities in our portfolio may be limited by, and subject to, the lack of or limited nature of a trading market for such securities. Therefore, we cannot assure you that we will be able to sell our portfolio company securities for amounts equal to the values that we have ascribed to them or at the time we desire to sell.

We are dependent on sales transactions, structured as tax-free exchanges to sell our intellectual property acquisition companies. A change in the Internal Revenue Code affecting tax-free exchanges could reduce our ability to sell our intellectual property acquisition companies.

We do not anticipate selling any of our intellectual property acquisition companies except in connection with these type of transactions. We anticipate that most, if not all, of such merger transactions will be structured as tax-free exchanges under Section 368 of the Internal Revenue Code. If Section 368 were to be amended so that we were no longer able to structure our merger transactions as tax-free exchanges, we may not be able to sell our intellectual property acquisition companies on commercially reasonable terms. If we are unable to successfully sell our intellectual property acquisition companies in a merger transaction, we may lose our investment.

The agreements we have with universities do not guarantee that the universities will grant licenses to us our intellectual property acquisition companies.

The agreements that we have entered into with universities provide us with the ability to evaluate the commercial potential for technologies at an early stage of development. These agreements, however, do not provide us with any guarantee that following our evaluation, a university will grant us a license. As a result, we may expend time and resources evaluating a technology and not be able to secure a license to such technology for us or one of our intellectual property acquisition companies.

We are dependent upon our management’s ability to identify portfolio companies to acquire our intellectual property acquisition companies.

Our investment strategy is based upon selling our intellectual property acquisition companies in stock for stock exchanges to portfolio companies that wish to acquire the technologies owned by our intellectual property acquisition companies but which they may be neither operating nor established. We do not expect to sell any securities of our intellectual property acquisition companies to the public. Therefore, if we fail to identify a portfolio company to acquire an intellectual property acquisition company, our entire investment could be lost.

We are dependent upon and have little or no control over the efforts of portfolio companies to successfully commercialize the acquired technologies or to retain the license to the technology.

We receive common stock from the portfolio company based upon the mutually agreed upon values of the intellectual property acquisition company, its licensed technology and the portfolio company. We then intend to sell the securities that we acquire in exchange for intellectual property acquisition companies at some time in the future. Therefore, our ability to profit from an investment is ultimately dependent upon the price we receive for the shares of the portfolio company. In most cases, the companies that acquire our intellectual property acquisition companies will be dependent upon successfully commercializing

Page 26 of 35

the technologies they acquire. We do not have control over the portfolio companies that acquire our intellectual property acquisition companies. These portfolio companies may face intense competition, including competition from companies with greater financial resources, more extensive research and development, manufacturing, marketing and service capabilities and a greater number of qualified and experienced managerial and technical personnel. They may need additional financing which they are unable to secure and we are unable or unwilling to provide or they may be subject to adverse developments unrelated to the technologies they acquire. They may lose the rights granted to them for the technology for failure to comply with the license agreement. We cannot assure you that any of the portfolio companies will be successful or that we will be able to sell the securities we receive at a profit or for sufficient amounts to even recover our initial investment in the portfolio companies or that our portfolio companies will not take actions that could be detrimental to us.

Our investments in our portfolio companies may be concentrated in one or more industries and if these industries should decline or fail to develop as expected our investments will be lost.

Our investments in our portfolio companies may be concentrated in one or more industries. This concentration will mean that our investments will be particularly dependent on the development and performance of those industries. Accordingly, our investments may not benefit from any advantages, which might be obtained with greater diversification of the industries in which our portfolio companies operate. If those industries should decline or fail to develop as expected, our investments in our portfolio companies in those industries will be subject to loss.

All of our portfolio investments are recorded at fair value as determined in good faith by our Board of Directors and, as a result, there is uncertainty regarding the value of our portfolio investments.

At June 30, 2004 and December 31, 2003, investments amounting to $19,963,515 or 86.0% of net assets and $7,745,354 or 69.5% of net assets, respectively, have been valued at fair value as determined by our Board of Directors. Pursuant to the requirements of the 1940 Act, the Board of Directors is responsible for determining in good faith the fair value of our investments for which market quotations are not readily available. Since there is typically no readily available market value for the investments in our portfolio, our Board of Directors determines in good faith the fair value of these investments pursuant to a valuation policy and a consistently applied valuation process. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to sell any of such investments, there is no assurance that the fair value, as determined by the Board of Directors, would be obtained. If we were unable to obtain fair value for such investments, there would be an adverse effect on our net asset value and on the price of our common stock.

We adjust quarterly the valuation of our portfolio to reflect the Board of Directors’ determination of the fair value of each investment in our portfolio. Any changes in fair value are recorded in our statement of operations as “Change in unrealized appreciation (depreciation) of non-controlled affiliate investments.”

Our business depends on key personnel.

We rely on, and will continue to be substantially dependent upon, the continued services of our management, principally our Chief Executive Officer and Chairman, Clifford M. Gross. Our management team is responsible for the review of potential investments by and the provision of advice to our portfolio companies regarding the acquisition of technologies and additional research and development. We also depend upon our management’s key contacts with universities to maintain our access to new technologies, and its relationships with companies in the private sector in order to effectuate the sale of our intellectual property acquisition companies.

Any transactions we engage in with affiliates may involve conflicts of interest.

The 1940 Act restricts transactions between us and any of our affiliates, including our officers, directors or employees and principal stockholders. In many cases, the 1940 Act prohibits transactions between such persons and ourselves unless we first apply for and obtain an exemptive order from the SEC. Delays and costs in obtaining necessary approvals may decrease or even eliminate any profitability of such transactions or make it impracticable or impossible to consummate such transactions. These affiliations could cause circumstances that would require the SEC’s approval in advance of proposed transactions by us in portfolio companies. Further, depending upon the extent of our management’s influence and control with respect to such portfolio companies, the selection of the affiliates of management to perform such services may not be a disinterested decision, and the terms and conditions for the performance of such services and the amount and terms of such compensation may not be determined at arm’s-length negotiations.

We have a limited amount of funds available for investment in either portfolio or intellectual property acquisition companies and, as a result, our investments will lack diversification.

Page 27 of 35

Based on the amount of our existing available funds, it is unlikely that we will be able to commit our funds to investments in, and the acquisition of, securities of a large number of companies. We intend to continue to operate as a non-diversified investment company within the meaning of the 1940 Act. Prospective investors should understand that our current investments are not, and in the future may not be, substantially diversified. We will not be able to achieve the same level of diversification as larger entities engaged in similar venture capital activities. Therefore, our assets may be subject to greater risk of loss than if they were more widely diversified, because the failure of one or more of our limited number of investments would have a material adverse effect on our financial condition and the price of our common stock.

If our portfolio companies fail to comply with the requirements of the forum in which their securities are quoted or the trading market on which their securities are listed, the liquidity and prices of our investments would be materially adversely affected.

At June 30, 2004, $19,193,036 or 96% of our total assets consisted of investments at fair value in companies whose securities are quoted on the OTC Bulletin Board or are listed on the American Stock Exchange. In order for the securities of our portfolio companies to be eligible for continued quotation on the OTC Bulletin Board or the American Stock Exchange, our portfolio companies must remain in compliance with certain listing standards. Among other things, these standards require that our portfolio companies remain current in their filings with the SEC and comply with certain of the provisions of the Sarbanes-Oxley Act of 2002. If our portfolio companies are no longer in compliance with these requirements, there would be no forum or market for the quotation or listing of the securities of our portfolio companies. Without such a forum or market, the liquidity and prices of our investments would be materially adversely affected. We cannot give any assurance that our portfolio companies will remain in compliance with the requirements to be quoted on the OTC Bulletin Board or listed on the American Stock Exchange.

We are subject to government regulations because of our status as a business development company.

We have elected to be treated as a BDC under the 1940 Act. The 1940 Act imposes numerous restrictions on our activities, including restrictions on the nature of our investments and transactions with affiliates. Any change in the law or regulations that govern our business could have a material impact on us or our operations. Laws and regulations may be changed from time to time, and the interpretations of the relevant laws and regulations also are subject to change.

One of our current stockholders has significant influence over our management and affairs.

Clifford M. Gross, our Chief Executive Officer and Chairman, beneficially owns approximately 37% of our common stock as of June 30, 2004. Therefore Dr. Gross may be able to exert influence over our management and policies. Dr. Gross may acquire additional equity in the future. The concentration of ownership may also have the effect of delaying, preventing or deterring a change of control of our company, could deprive our shareholders of an opportunity to receive a premium for their common stock as part of the sale of our company and might ultimately affect the market price of our common stock.

ITEM 3. Qualitative and Quantitative Disclosures About Market Risks

          There has been no material change in the qualitative and quantitative disclosures about market risk since December 31, 2003.

ITEM 4. CONTROLS AND PROCEDURES

     Disclosure Controls and Procedures

     As of the end of the period covered by this quarterly report on Form 10-Q, the Company’s principal executive officer and principal financial officer conducted an evaluation of the effectiveness of the design and operations of its disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective in timely altering them to material information relating to the Company, including its consolidated subsidiaries, that is required to be disclosed in the reports it files or submits under the Securities Exchange Act of 1934.

     Internal control over financial reporting

     There have been no significant changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934) that occurred during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect the Company’s internal control over financial reporting.

Page 28 of 35

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

     Although the Company may from time to time be involved in litigation and claims arising out of its operations in the normal course of its business, as of June 30, 2004, the Company was not a party to any material pending legal proceedings.

Item 2. Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

     On April 23, 2004, the Company issued 100,000 shares of common stock for an aggregate offering price of $1,000,000 to accredited investors pursuant to an exception from the registration requirements of the Securities Act of 1933 as amended under Section 4(2) of the Securities Act or Regulation D promulgated thereunder as transactions by an issuer not involving any public offering. GunnAllen Financial, Inc. acted as placement agent in connection with the offering of such shares and received an aggregate commission of $100,000 for its services in connection therewith.

Item 3. Defaults upon Senior Securities

     Not Applicable.

Item 4. Submission of Matters to a Vote of Security Holders

     The Company held its annual meeting of stockholders on June 25, 2004. Shareholders voted on five matters; the substance of these matters and the results of the voting of each such matter are described below. There were no broker non-votes for either matter.

     The first item was to elect seven directors: Clifford Gross, Stuart Brooks, Sam Reiber, Kwabena Gyimah-Brempong, Arthur Chapnik, John Micek and Keith Witter were elected to continue their terms. Clifford Gross received 4,595,426 votes in favor, 11,023 votes withheld. Kwabena Gyimah-Brempong, Arthur Chapnik and Keith Witter received votes 4,595,926 in favor, 10,523 votes withheld. , John Micek received votes 4,595,826 in favor, 10,623 votes withheld. Stuart Brooks received 4,562,026 votes in favor, 44,423 votes withheld. Sam Reiber received 4,579,726 votes in favor, 26,723 votes withheld

     The second item brought for a vote at the annual meeting of stockholders was to approve an amendment to the existing Company’s 1999 Employee Stock Option Plan to increase the number of shares of common stock authorized for issuance under the plan by 185,000 shares. Votes cast were as follows: 3,206,510 votes for the proposal, 69,283 against, and 17,970 abstentions.

     The third item brought for a vote at the annual meeting of stockholders was to approve an amendment to the Company’s existing 2000 Non-Qualified Stock Option Plan to increase the number of shares of common stock authorized for issuance under the plan by 65,000 shares. Votes cast were as follows: 3,204,535 votes for the proposal, 69,283 against, and 19,945 abstentions.

     The fourth item brought for a vote at the annual meeting of stockholders was to authorize the issuance from time to time of warrants to purchase shares up to 50,000 shares of common stock of the Company. Votes cast were as follows: 3,283,955 votes for the proposal, 42,858 against, and 16,950 abstentions

     The fifth item brought for a vote at the annual meeting of stockholders was to ratify the selection of Pender Newkirk and Company as the Company’s independent accountants for the year ending December 31, 2004. Votes cast were as follows: 4,581,056 votes for the proposal, 18,343 against, and 7,050 abstentions.

Item 5. Other Information

     Not applicable.

Item 6. Exhibits and Reports on Form 8-K

(a) List of exhibits.

a.

The following exhibits are filed with this report or are incorporated herein by reference to a prior filing, in accordance with Rule 12b-32 under the Securities Exchange Act of 1934.

Page 29 of 35

(b) Reports on Form 8-K.

               On May 4, 2004, the Company filed a Form 8-K pursuant to Items 5 and 7 reporting that Web Safe Technologies, Inc., a Florida corporation and 100% owned subsidiary of the Company was acquired by Zkid Network Company in a tax-free stock-for-stock exchange.

               On May 10, 2004, the Company furnished a Form 8-K pursuant to Item 12 reporting the issuance of a press release announcing the Company’s financial results for the quarter March 31, 2004.

Page 30 of 35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UTEK CORPORATION           (Registrant)
Date: August 5, 2004	/s/ Clifford M. Gross
	Clifford M. Gross
	Chairman and Chief Executive Officer

Date: August 5, 2004	/s/ Carole R. Wright
	Carole R. Wright, CPA
	Chief Financial Officer

Page 31 of 35